Supply of Remdesivir
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £3,813,494 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 5 Jan 2021 |
| Contract start | 5 Jan 2021 |
| Contract end | 31 Jan 2021 |
| Procedure | selective |
| SME suitable | No |
| OCID | ocds-b5fd17-db0d6a36-2b3a-4ae9-bef5-835f34bdd699 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Gilead Sciences Limited | £3,813,494 | 5 Jan 2021 | active |
description
This contract is call off no.5 from a EU Framework Agreement for the Supply of Remdesivir.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 31 Mar 2021 | Award (award) | · | d015146f-7762-44d8-9776-4cb65a663374-425256 |
more from Department of Health and Social Care (DHSC)
- Hugh's Report-MH Impact of Life-threatening Child Illness on families 2026 · £216,540 · 26 Jun 2026
- D&B + API Interface · £542,011 · 25 Jun 2026
- NCMP IT System - Discovery Phase · £183,768 · 19 May 2026
- DHSC: CL Temporary Executive Support to the Permanent Secretary - JW · £17,702 · 19 May 2026
- DHSC: GO: 26/27 - WIST: DAC hosting on CSP · £168,000 · 2 Apr 2026
- RM1043.8-1-DEPARTMENT OF HEALTH AND SOCIAL CARE - Find Public Health Data · £1,251,360 · 2 Apr 2026
- DHSC:NHST: National GP Engagement on Health Data · £267,000 · 31 Mar 2026
- DHSC: CL FGO Contingent Labour SD Extension · £133,710 · 31 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.